Safety of Sabin Inactivated Poliovirus Vaccine in Adults, Children and Infants and Lot Consistency Immunogenicity, and Safety of the msIPV in 2 Months Old Infants
Condition: Poliomyelitis Interventions: Biological: Experimental vaccine; Biological: IPV control vaccine; Biological: single-person sIPV control vaccine Sponsor: Sinovac Biotech Co., Ltd Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 23, 2022 Category: Research Source Type: clinical trials